Clinical Trial Update: A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

IDEAYA Biosciences is conducting a Phase 1/2 study to evaluate the safety, pharmacokinetics, and preliminary efficacy of IDE574 in adults with advanced solid tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Colorectal Cancer
• Estrogen Receptor-positive Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• IDE574 (IDE574)

Snippet

Sponsor: IDEAYA Biosciences | Conditions: ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC) | Phase 1, Phase 2 | Status: RECRUITING